Madrigal Pharmaceuticals (MDGL) Debt Ratio (2022 - 2025)
Madrigal Pharmaceuticals (MDGL) has disclosed Debt Ratio for 10 consecutive years, with 0.27 as the latest value for Q4 2025.
- On a quarterly basis, Debt Ratio rose 139.21% to 0.27 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.27, a 139.21% increase, with the full-year FY2025 number at 0.27, up 139.21% from a year prior.
- Debt Ratio was 0.27 for Q4 2025 at Madrigal Pharmaceuticals, up from 0.25 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.48 in Q3 2023 to a low of 0.11 in Q2 2024.
- A 4-year average of 0.21 and a median of 0.18 in 2023 define the central range for Debt Ratio.
- Peak YoY movement for Debt Ratio: crashed 77.37% in 2024, then soared 139.21% in 2025.
- Madrigal Pharmaceuticals' Debt Ratio stood at 0.14 in 2022, then surged by 32.62% to 0.18 in 2023, then tumbled by 37.43% to 0.11 in 2024, then soared by 139.21% to 0.27 in 2025.
- Per Business Quant, the three most recent readings for MDGL's Debt Ratio are 0.27 (Q4 2025), 0.25 (Q3 2025), and 0.12 (Q2 2025).